Medical Oncologist
Hyderabad's Dedicated Stomach Cancer Network · NCCN protocols · 11 city centres + 35 partner centres
Best Stomach Cancer Hospital in Hyderabad - 11 Centres, NCCN Protocols, NABH-Accredited Partners
Choosing a stomach cancer hospital is about three things: a surgical team that performs gastrectomy with proper D2 lymph node dissection at high volume, a medical oncology team that uses the modern FLOT perioperative chemotherapy protocol before and after surgery, and a pathology team that runs the biomarker testing needed to identify HER2-positive and other targetable tumour subtypes. CION runs Hyderabad's dedicated stomach cancer network.
- High-volume D2 gastrectomy - via NABH-accredited partner hospitals with verified upper GI surgical expertise
- Modern FLOT perioperative chemotherapy - given before AND after surgery, the new standard for stage II-III disease
- Full biomarker testing on every biopsy - HER2, MSI, PD-L1, Claudin 18.2. Treatment never chosen blind.
- Tumour-board governance - written summary of the multidisciplinary review, yours to keep
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The CION Stomach Cancer Panel
Stomach cancer is a team game. Meet the CION panel.
Surgical oncology, medical oncology, radiation oncology, and partner-network gastroenterology - coordinated through one tumour board. Same panel, same NCCN protocols at every centre.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Why hospital choice decides everything
Why the hospital matters more than the building
Most patients begin by searching for the best stomach cancer doctor in Hyderabad. The doctor matters — but stomach cancer is a disease where the protocol matters as much as the person. A meaningful proportion of stomach cancers globally are linked to a treatable bacterial infection called H. pylori, an important fact for prevention. For those already diagnosed, the central decisions are whether the surgery is a proper gastrectomy with adequate D2 lymph node dissection, whether modern perioperative FLOT chemotherapy is delivered correctly before and after surgery, and whether biomarker testing identifies tumours that respond to specific targeted treatments such as trastuzumab for HER2-positive cancers and immunotherapy for cancers with mismatch repair deficiency or high PD-L1 levels.
This page gives you an honest framework — eight institutional signals that separate hospitals that can manage stomach cancer well from hospitals that simply offer the service — and explains how CION is built around them. Use the framework on every hospital you shortlist. If a hospital can't answer in writing, it should fall off your list.
Did you know?
The modern FLOT chemotherapy protocol — given as four cycles before surgery and four cycles after surgery for stage II-III stomach cancer — has substantially improved 5-year survival compared to the older standard chemotherapy regimens it replaced. The FLOT4 trial showed that this perioperative approach (rather than chemotherapy only after surgery, or only before) is the new standard of care. The hospital you choose directly determines whether you receive this modern protocol correctly. Source: FLOT4 trial · NCCN guidelines.
11 city centres in Hyderabad · Closer than you think
CION stomach cancer care, in the neighbourhood you live in.
Surveillance endoscopy, biomarker testing, day-care FLOT chemotherapy, nutritional follow-up, and clinical reviews happen at the centre nearest you. Complex gastrectomy, laparoscopic and robotic gastric surgery, and endoscopic resection run through NABH-accredited partners with verified upper GI surgical expertise — same panel, same protocols, same tumour board at every site.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Decision framework
8 things that make a hospital genuinely the best for stomach cancer in Hyderabad
These are the eight institutional signals that matter most for stomach cancer. Each is verifiable. Each is non-negotiable. Ask the question, get it in writing, and walk away if you can't.
A gastrointestinal-oncology-trained multidisciplinary team
Stomach cancer treatment combines surgery, chemotherapy given before and after surgery, sometimes immunotherapy or targeted therapy, and long-term nutritional support after gastrectomy. The team needs a surgical oncologist with high-volume gastrectomy experience, a medical oncologist experienced with the FLOT perioperative chemotherapy protocol and modern biologics like trastuzumab and pembrolizumab, a radiation oncologist for the small number of cases where radiation is part of the plan, a gastroenterologist who can perform diagnostic and surveillance endoscopy with endoscopic ultrasound, a pathologist with experience interpreting HER2, MSI, PD-L1, and Claudin 18.2 testing, and a nutritionist for long-term post-gastrectomy nutritional care.
Walk away if the hospital cannot name who interprets your biomarker tests and who plans your post-surgery nutrition.
Tumour-board review with TNM staging and biomarker discussion
A stomach cancer tumour board reviews your scans, endoscopy findings, biopsy results, and biomarker tests (HER2, MSI/mismatch repair status, PD-L1 levels, Claudin 18.2 status) together. The board assigns a TNM stage, debates the surgical approach (open, laparoscopic, or robotic gastrectomy; total or subtotal resection), agrees on the chemotherapy regimen — particularly whether the patient is fit for the four-drug FLOT combination — and reviews biomarker-driven options like trastuzumab for HER2-positive cancers.
Walk away if surgery is scheduled in the first consultation without a documented tumour-board discussion that includes biomarker results.
Annual gastrectomy volume with proper D2 lymph node dissection
Stomach cancer surgery has a strong volume-outcome relationship: high-volume surgical teams demonstrate better survival, lower post-operative complications, and most importantly a more thorough lymph node dissection. The standard for curative-intent surgery is called D2 lymphadenectomy — removal of the lymph nodes immediately around the stomach along with the next-level nodes along major blood vessels. The number of lymph nodes removed is a measurable quality indicator: international guidelines recommend retrieving at least 15-16 nodes. Ask: "How many gastrectomies did your team perform last year? Do you routinely perform D2 lymphadenectomy? What is the average lymph node yield in your specimens?" Specific numbers indicate transparency.
Walk away if the team cannot describe their D2 lymphadenectomy approach or quote an average node count.
Endoscopy, endoscopic ultrasound, and biomarker testing infrastructure
Stomach cancer is diagnosed by upper GI endoscopy with biopsy. Once cancer is confirmed, endoscopic ultrasound — using a slim ultrasound probe passed down through the mouth — adds critical detail about how deeply the tumour has invaded the stomach wall. Contrast CT of the chest, abdomen, and pelvis assesses spread. Biomarker testing on the biopsy — for HER2, mismatch repair status (MSI), PD-L1 levels (using a score called CPS), and the newer Claudin 18.2 marker — determines which patients qualify for targeted therapies and immunotherapy. Without these tests, treatment is being chosen blind.
Walk away if the hospital does not run HER2 and PD-L1 testing on every stomach cancer biopsy.
Day-care FLOT chemotherapy close to home
The modern standard for stage II-III stomach cancer is the FLOT chemotherapy protocol — a four-drug combination (5-FU, leucovorin, oxaliplatin, and docetaxel) given as four cycles before surgery, followed by surgery, then four more cycles after surgery. Each cycle is a multi-hour infusion every two weeks for eight cycles total — meaning eight months of regular hospital visits during chemotherapy. For HER2-positive metastatic disease, the regimen adds trastuzumab and pembrolizumab. For mismatch repair-deficient or PD-L1-high cases, pembrolizumab plays a central role.
Walk away if all chemotherapy is administered at one campus only — that's a logistical burden over eight months of treatment.
NABH-accredited partners for laparoscopic, robotic, and complex gastrectomy
Stomach cancer surgery is performed open, laparoscopically (keyhole), or robotically depending on tumour location, stage, and surgeon experience. Modern minimally invasive approaches reduce recovery time but require specific surgical expertise and equipment. For very early stomach cancer (T1a stage), endoscopic resection (ESD) — removing the cancer through an endoscope without open surgery — is an option. NABH-accredited partners signal audited surgical and procedural safety.
Walk away if the hospital offers only one surgical approach and cannot discuss alternatives that may be better for your case.
Insurance, ArogyaSri, and TPA empanelment in writing
Stomach cancer treatment is a substantial financial commitment — surgery, eight cycles of FLOT chemotherapy over many months, and biologic therapies for HER2-positive or PD-L1-high cases that add significantly to the bill. A hospital that isn't empanelled for your insurance or ArogyaSri at the specific centre where your procedure happens can derail planning at the worst moment.
Walk away if cost estimates change after admission — a serious hospital writes them down beforehand.
Continuity of care and post-gastrectomy nutritional management
Patients who have had a gastrectomy live with permanent changes to digestion. The stomach's normal functions — holding food, mixing it with acid, releasing it gradually into the small intestine — are altered or lost. Common long-term issues include vitamin B12 deficiency (requiring lifelong supplementation), iron deficiency, a condition called dumping syndrome where food empties rapidly into the small intestine causing dizziness and abdominal symptoms, persistent weight loss, and bone density loss. You will see your team frequently — for surveillance endoscopy and scans, nutritional reviews, B12 injections, and management of any side effects.
Walk away if you're told you must travel to one campus for every nutritional review and follow-up endoscopy for the next five years.
Hospital archetype
Cancer-specialty network vs multi-specialty hospital vs Ayurveda - which is structurally right for stomach cancer?
Hyderabad has all three models. They are not interchangeable. The right one depends on whether you have access to a high-volume gastrectomy surgeon and whether the medical oncology team delivers the modern FLOT chemotherapy protocol. Here's an honest comparison.
| Hospital archetype | Strengths for stomach cancer | Trade-offs | Best fit for |
|---|---|---|---|
| Dedicated cancer-specialty hospital or network | Tumour-board review with biomarker discussion. Day-care FLOT chemotherapy infrastructure. Tight oncology coordination. Established protocols for trastuzumab and immunotherapy. Partner pathway for laparoscopic and robotic gastrectomy. | Gastrectomy itself coordinated through surgical partners. Strong networks solve this with NABH-accredited tie-ups to high-volume upper GI surgical centres. | Most stomach cancer patients — across all stages where modern perioperative chemotherapy and biomarker-driven therapy matter. |
| Multi-specialty general hospital with in-house upper GI surgery | In-house gastrectomy team if high-volume. Single-campus coordination across surgery, gastroenterology, and intensive care. | Medical oncology depth varies. Biomarker testing turnaround may be slower. FLOT chemotherapy delivery depends on the medical oncology service quality. | Patients prioritising single-campus care if and only if the hospital's annual gastrectomy volume and FLOT chemotherapy expertise are both verifiable. |
| Ayurveda hospital | Symptom palliation and post-treatment recovery support. Some patients value the holistic framing. | Not evidence-based as primary curative treatment. Should never delay gastrectomy or FLOT chemotherapy in stomach cancer — where time-to-treatment matters. | Strictly as an add-on to allopathic oncology care. Discuss any Ayurveda use openly with your medical oncologist — many herbal preparations interact with chemotherapy drugs. |
The structurally correct default for most stomach cancer patients is a dedicated cancer-specialty hospital or network with NABH-accredited partners for gastrectomy. This combines tight oncology workflows — modern chemotherapy protocols, biomarker testing, immunotherapy capability — with access to verified high-volume surgical expertise. This is precisely how CION is built.
Why CION - institutional answer
How CION is built for stomach cancer at an institutional level
CION is not a single hospital. It is a dedicated cancer-specialty network — 11 centres across Hyderabad and 35+ partner centres across Telangana and Andhra Pradesh — with the same panel of oncologists, the same NCCN protocols, and the same tumour-board governance at every site. The network is architected specifically around the eight signals above.
A network architecture, not a building
Hospital infrastructure for stomach cancer is tiered at CION. Surveillance endoscopy, biomarker testing, day-care FLOT chemotherapy, nutritional follow-up, B12 monitoring, and clinical reviews happen at the centre nearest your home. Total or subtotal gastrectomy with D2 lymphadenectomy, laparoscopic and robotic gastrectomy, and endoscopic resection for very early cancer run through NABH-accredited partner hospitals with verified upper GI surgical expertise. The same panel of oncologists that consults at one centre stays with you across the network.
Endoscopy, endoscopic ultrasound, and full biomarker workup
Upper GI endoscopy with biopsy is the diagnostic foundation, and endoscopic ultrasound for accurate T-staging is coordinated through partner gastroenterology services. CT and MRI imaging are available across six CION centres in Hyderabad. Crucially, every stomach cancer biopsy is routed through full biomarker testing — HER2, mismatch repair status (MSI), PD-L1 with CPS scoring, and Claudin 18.2 — through integrated lab pathways. Treatment is biomarker-driven from the start, not chosen blind.
Identifying inherited stomach cancer
A small but important subgroup of stomach cancers — particularly diffuse-type cancers in younger patients or those with a family history — are linked to inherited gene mutations such as CDH1 (a condition called hereditary diffuse gastric cancer). CION arranges genetic testing through integrated lab pathways where family history or clinical features suggest an inherited cause, with genetic counselling for patients and at-risk family members.
NCCN-protocol FLOT chemotherapy at every centre
All 11 CION centres in Hyderabad have day-care infusion bays. The modern FLOT perioperative chemotherapy protocol, capecitabine + oxaliplatin (CAPOX), trastuzumab combined with chemotherapy and pembrolizumab for HER2-positive disease, nivolumab combination therapy for PD-L1-positive cases, and pembrolizumab monotherapy for mismatch repair-deficient tumours are all administered close to home. Oncology-trained nursing, hypersensitivity-reaction protocols for taxanes and platinums, and on-site oncologist supervision are standard at every centre.
NABH-accredited partner network for gastrectomy and advanced procedures
Where a stomach cancer case requires total or subtotal gastrectomy with D2 lymphadenectomy, laparoscopic or robotic gastrectomy, endoscopic resection for very early cancer, or diagnostic laparoscopy to confirm absence of peritoneal disease before major surgery, CION coordinates the procedure through NABH-accredited partner hospitals with high annual upper GI surgical volume. NABH accreditation ensures audited compliance with patient-safety, infection-control, and clinical-governance protocols.
Post-gastrectomy nutritional support and supportive oncology
Patients who have had a gastrectomy face permanent digestive changes. Lifelong B12 supplementation (usually as injections), iron replacement when needed, dietary counselling to manage smaller meals more frequently and avoid dumping syndrome, weight monitoring and intervention when weight loss is significant, bone density monitoring with calcium and vitamin D supplementation, surveillance endoscopy at defined intervals, and management of any chemotherapy side effects are all coordinated within the CION network. These are not afterthoughts — they decide whether your recovery is uncomplicated or whether nutritional decline leads to re-admission.
Tumour-board governance on every stomach cancer case
Every stomach cancer case at CION is reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board debates the TNM stage, fitness for the FLOT chemotherapy protocol, surgical approach (open, laparoscopic, or robotic), gastrectomy extent (total vs subtotal), lymph node dissection plan, biomarker-driven targeted therapy decisions for HER2-positive or PD-L1-high cases, and post-surgery surveillance planning. The board produces a written summary that becomes part of your records — and yours to keep. You can take it to any second opinion, anywhere.
Network proof - outcomes & credentials
CION's institutional numbers - verifiable, not adjectival
Specifics beat vague claims. Here is the verifiable network footprint behind CION's stomach cancer pathway.
| Network metric | CION figure |
|---|---|
| City centres in Hyderabad | 11 |
| Partner centres across Telangana & Andhra Pradesh | 35+ |
| Centres with CT, MRI & PET-CT diagnostics | 6 |
| Day-care chemotherapy infusion bays | All 11 city centres |
| Cancer specialists on panel | 17+ |
| Patients treated network-wide | 15,000+ |
| Stomach cancer cases managed annually | 1,000+ per year |
| Google review rating | 4.8★ (800+ reviews) |
| Gastrectomy & advanced procedure partner accreditation | NABH-accredited |
| Biomarker testing (HER2, MSI, PD-L1, Claudin 18.2) on every biopsy | Yes — routine |
| Tumour-board review on every case (TNM staging + biomarker discussion) | Yes — written summary |
| Written second opinion | Free (worth ₹950) |
| Insurance and ArogyaSri accepted | Yes — empanelled |
| EMI facility for self-paying patients | Available on selected packages |
Insurance, ArogyaSri & cost transparency
Financial clarity is part of clinical care.
Stomach cancer treatment is a substantial financial commitment — surgery, eight cycles of FLOT chemotherapy over many months, and biologic therapies for HER2-positive or PD-L1-high cases that add significantly to the total. CION provides a written, itemised treatment plan and cost estimate before any decision is finalised.
- ArogyaSri empanelment — eligible patients can access state-scheme coverage at empanelled CION centres.
- Cashless insurance — most major insurers and TPAs accepted, with pre-authorisation handled by the CION insurance desk.
- EMI facility — available for self-paying patients on selected treatment packages.
- Written cost estimate — surgery, endoscopy, biomarker testing, chemotherapy, targeted therapy or immunotherapy, and post-surgery supportive care are itemised before treatment begins.
Targeted therapies (trastuzumab) and immunotherapy (pembrolizumab, nivolumab) have specific scheme rules. The CION insurance desk will confirm coverage and pre-authorisation requirements before your treatment begins. Ask for written confirmation.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Frequently asked questions about choosing a stomach cancer hospital in Hyderabad
Which is the best stomach cancer hospital in Hyderabad?
No single hospital is automatically best — and for stomach cancer, the most important hospital signals are the surgical team's annual gastrectomy volume, the quality of lymph node dissection (the D2 technique), and whether the medical oncology team uses the modern FLOT perioperative chemotherapy protocol that has substantially improved outcomes. Look for a multidisciplinary team experienced in gastric cancer, NCCN protocols, endoscopic ultrasound capability, biomarker testing (HER2, MSI, PD-L1, Claudin 18.2), day-care chemotherapy, and NABH-accredited surgical partners. CION Cancer Clinics meets these criteria with 11 centres across Hyderabad and 1,000+ stomach cancer cases managed every year.
How do I choose the right stomach cancer hospital in Hyderabad?
Verify eight signals in writing: gastrointestinal-oncology-trained multidisciplinary team, tumour-board review with TNM staging and biomarker discussion, annual gastrectomy and D2 lymphadenectomy volume, endoscopic ultrasound and biomarker-testing infrastructure, day-care FLOT chemotherapy near home, NABH-accredited partners for laparoscopic and robotic gastrectomy, insurance and ArogyaSri empanelment, and continuity of care including post-gastrectomy nutritional management. If a hospital can't answer clearly on each, drop it from your shortlist.
What is the success rate of stomach cancer treatment in Hyderabad?
Outcomes depend strongly on stage at diagnosis and on whether modern protocols are used. Per US National Cancer Institute SEER data, 5-year relative survival for stomach cancer is approximately 75% if caught while limited to the stomach, 35% for regional spread, and 7% for distant spread — with an overall average of about 36% across all stages combined. For stage II-III stomach cancer treated with the modern FLOT chemotherapy protocol (given before and after surgery) combined with high-quality D2 surgery, 5-year survival commonly reaches 45-55%. The hospital you choose directly affects whether you receive modern FLOT chemotherapy and high-quality D2 surgery.
How much does stomach cancer treatment cost in Hyderabad?
Costs vary by stage and pathway. Indicative ranges: total or subtotal gastrectomy ₹2-5 lakh; laparoscopic or robotic gastrectomy ₹4-8 lakh (via NABH-accredited partner); endoscopic resection (ESD) for very early cancer ₹50,000-1.5 lakh; FLOT chemotherapy ₹50,000-1 lakh per cycle (8 cycles total over treatment course); trastuzumab + chemotherapy for HER2-positive cases ₹1.5-2.5 lakh per cycle; pembrolizumab immunotherapy ₹1.5-2 lakh per cycle; endoscopic ultrasound ₹15,000-30,000; biomarker testing panel ₹15,000-40,000. CION provides a written treatment plan and itemised cost estimate before treatment begins, with an EMI facility available on selected packages.
Should I choose a cancer-specialty hospital or a multi-specialty hospital for stomach cancer?
For stomach cancer, what matters most is the surgical team's gastrectomy volume and the medical oncology team's experience with the modern FLOT protocol. A cancer-specialty hospital or network usually offers tighter oncology workflows — tumour-board review, dedicated chemotherapy day-care, oncology-trained nursing, biomarker testing, and faster access across medical, surgical, and radiation oncology. A multi-specialty general hospital with a high-volume upper GI surgery program can also be a good fit. For most stomach cancer patients, the cancer-specialty pathway with NABH-accredited surgical partners offers the best balance of modern systemic therapy and surgical safety.
Is laparoscopic or robotic gastrectomy available for stomach cancer in Hyderabad?
Yes. Laparoscopic and robotic gastrectomy are available in Hyderabad at select centres with experienced upper GI surgical teams. CION coordinates these advanced minimally invasive procedures through NABH-accredited partner hospitals, with the CION oncology team managing perioperative chemotherapy. For early-stage gastric cancer (T1a), endoscopic resection (called ESD) is an option that avoids open surgery entirely. The choice between open, laparoscopic, and robotic gastrectomy depends on tumour stage, location, surgeon experience, and patient factors — discussed at tumour board.
Is FLOT chemotherapy and HER2-targeted therapy available for stomach cancer in Hyderabad?
Yes. FLOT chemotherapy — the modern standard given as 4 cycles before surgery and 4 cycles after surgery for stage II-III stomach cancer — is routinely administered in Hyderabad and has substantially improved outcomes compared to older protocols. For HER2-positive stomach cancer (around 15-20% of cases), trastuzumab combined with chemotherapy and pembrolizumab is the modern first-line standard. For tumours with mismatch repair deficiency (MSI-H) or high PD-L1 levels, immunotherapy is part of the standard pathway. CION administers all of these regimens at day-care infusion bays across the network, with full biomarker testing arranged before treatment begins.
Do stomach cancer hospitals in Hyderabad accept ArogyaSri and private insurance?
Many qualified hospitals are empanelled for ArogyaSri and most major cashless insurers — but empanelment varies by centre and by procedure. Targeted-therapy drugs such as trastuzumab and immunotherapy in particular have specific scheme rules. CION Cancer Clinics is empanelled for ArogyaSri and accepts most major cashless insurance providers and TPAs. Request a written cost estimate and confirm pre-authorisation before treatment begins, especially for gastrectomy and biologic therapies.
Are stomach cancer hospitals in Hyderabad NABH accredited?
Several Hyderabad hospitals hold NABH accreditation — the Indian healthcare quality standard covering patient safety, infection control, and clinical governance. CION's partner hospitals for gastrectomy, laparoscopic and robotic gastric surgery, and advanced endoscopic procedures are NABH-accredited, giving patients audited assurance on infection control and surgical safety for these complex procedures.
What facilities should I check before admitting for stomach cancer surgery?
Confirm in writing: dedicated upper GI operating theatre, surgeon's annual gastrectomy volume and approach to D2 lymph node dissection, endoscopy and endoscopic ultrasound capability, biomarker testing turnaround (HER2, MSI, PD-L1), post-operative ICU with experience in upper GI surgery recovery, blood-bank access for major surgery, in-house or networked chemotherapy day-care for FLOT before and after surgery, NABH accreditation of the surgical partner, nutritional support for managing post-gastrectomy digestive changes including B12 supplementation, room categories, and a clear written cost estimate.
Your next decision matters. Make it with the right team.
Book a free consultation with a senior CION stomach cancer specialist. Tumour-board review and a written second opinion — yours to keep and take anywhere.
Medical Disclaimer: The information on this page is provided for general educational purposes and reflects current clinical practice in stomach cancer oncology at the time of last medical review. It is not a substitute for individual medical advice, diagnosis, or treatment. Treatment decisions, drug choices, dosing, surgical approach, and follow-up schedules must be made by a qualified physician evaluating the specific patient. Survival statistics cited are population-level estimates drawn from public registries and do not predict outcomes for an individual case. Always discuss your specific situation with a qualified medical or surgical oncologist before acting on any information presented here.
Last Medically Reviewed: May 2026 by Dr. Muralidhar Muddusetty — Surgical Oncologist, MBBS (AIIMS), MS Surgery (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh).